Please note this page is a work in progress and URLs will be attached to each publication in due course.


Bachelot T, Jerusalem G, Cikalo M, McCool R, King S, Duffy S, et al. Comparative efficacy of everolimus versus fulvestrant for hormone-receptor–positive (HR+) advanced breast cancer (ABC) following progression/recurrence after first-line treatment: A network meta-analysis. J Clin Oncol. 2013;31(Suppl):e11602 (Published in conjunction with the 2013 ASCO Annual Meeting).

NICE Guidance. Willits I, Reay CA, Keltie K, Craig JA, Duffy C, Sims AJ. WatchBP Home A for diagnosing and monitoring hypertension and detecting atrial fibrillation (MTG13). NICE External Assessment Centre Report. January 2013.

NICE Guidance. Willits I, Keltie K, Craig JA, Sims AJ. WatchBP Home A for diagnosing and monitoring hypertension and detecting atrial fibrillation (MTG13). NICE External Assessment Centre Additional Work Supplement: Cost impact of the WatchBP Home A used in a primary healthcare clinic environment. January 2013.

[MTEP] Keltie K, Reay CA, Bousfield DR, Cole H, Ward B, Oates CP, Sims AJ. Characterization of the ultrasound beam produced by the MIST therapy, wound healing system. Ultrasound Med Biol. 2013; 39(7): 1233‑40

Clark Laura; Fairhurst Caroline; Hewitt Catherine Elizabeth; Birks Yvonne Frances; Brabyn Sally Elizabeth; Cockayne Sarah; Rodger, Sara Anita; Hicks Kate; Hodgson Robert; Littlewood Liz; Torgerson David John.  Assessing the presence of selection bias in meta-analyses of randomised trials using baseline heterogeneity.  In: Trials, Vol. 14, No. Supp 1, 096, 2013.

Green W, Hutton J.  Health Technology Assessments in England: An Analysis of the NICE Medical Technologies Evaluation Programme.  European Journal of Health Economics 2013 15(5): 449-452.

Darba J, Kaskens L, Abecassis M, Carrasco J, Vitorino R, Taylor MJ.  Coste-efectividad de dasatinib frente a dosis altas de imatinib y nilotinib en pacientes con leucemia mieloide cronica resistente a la dosis estandar de imatinib en Portugal.  Pharamacoecon Span Res Artic.  Published online 20 December 2013.

[MTEP] Goode SD, Keltie K, Burn J, Patrick H, Cleveland T, Campbell B, Gaines P, Sims AJ. Effect of procedure volume on outcomes after iliac artery angioplasty and stenting. Br J Surg. 2013; 100(9): 1189-96

Chaplin S, Jenks M, Craig JA.  Warfarin Monitoring: Economic Evaluation of Point-of-Care Tests Compared to Clinic Settings.  Journal of Medical Economics.  Published online 19 December 2013.

Parker G, Spiers G, Gridley K, Atkin K, Birks Y, Lowson K, Light K.  Systematic Review of International Evidence on the Effectiveness and Costs of Paediatric Home Care for Children and Young People Who are Ill.  Child Care Health Development 2013 Jan; 39(1):1-19.

[MTEP] Patrick H, Sims AJ, Burn J, Bousfield DR, Colechin E, Reay CA, Alderson N, Goode S, Cunningham  D,  Campbell B. Monitoring the use and outcomes of new devices and procedures: how does coding affect what Hospital Episode Statistics contribute? Lessons from 12 emerging procedures 2006–10. J Public Health (Oxf). 2013; 35(1): 132-8

Bachelot T, McCool R, Duffy S, Glanville JM, Varley D, Fleetwood K, Zhang J, Jerusalem G.  Comparative efficacy of everolimus plus exemestane versus fulvestrant for hormone-receptor-positive advanced breast cancer following progression/recurrence after endocrine therapy: a network meta-analysis. Breast Cancer Res Treat. 2013 Nov 24.

Lefebvre C, Glanville J, Wieland LS, Coles B and Weightman A.  Methodological developments in searching for studies for systematic reviews: past, present and future? Systematic Reviews 2013, 2:78 (25 September 2013)

Beynon R, Leeflang MM, McDonald S, Eisinga A, Mitchell RL, Whiting P, Glanville JM. Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE. Cochrane Database of Systematic Reviews 2013, Issue 9. Art. No.: MR000022. DOI: 10.1002/14651858.MR000022.pub3

Arber M, Cikalo M, Glanville J, Lefebvre C, Varley D, Wood H.  Annotated Bibliography of Published Studies Addressing Searching for Unpublished Studies and Obtaining Access to Unpublished Data.  York: York Health Economics Consortium; 2013.

Bartlett C, Hex N.  Cost-effectiveness of Follow-up Services for Childhood Cancer Survivors Outside the Cancer Setting.  Current Opinion in Supportive Palliative Care.   September 2013:7(3) 314-317.

Burke M, Hacking N, Wright M, Iqbal K, Craig J.  Economic evaluation of early TIPS procedures with ePTFE covered stent-grafts compared to endoscopic procedures to manage acute variceal bleeding.  Journal of Hepatology 2013;58 (Supplement 1):S 252.

Rowland I, Crittenden R, King S, Kleiner J, Mathioudakis B.  The Nutrition and Health Claims Regulation – Striking the Balance for Consumers, Regulators and Industry: The Promise of Probiotics.  February 2013.  Report from European Parliament Workshop held on 19 February 2013.

Aiassa E, Glanville J, et al.  Applicability and feasibility of systematic review for performing evidence-based risk assessment in food and feed safety.  Critical Reviews in Food Science and Nutrition.  2013.  In Press.

Craig J, Shenton R, Smith A.  Economic Analysis of Soft-Heel Casting for Diabetic Foot Ulcer: Prevention and Treatment.  Journal of Wound Care, 2013:22(1) 44-48.

Dignan FL, Potter MN, Ethell ME, Taylor MJ, Lewis L, Brennan J, McNamara L, Evans SO, Riley U, Davies FE, Dearden CE, Morgan GJ, Shaw BE. High Readmission Rates are Associated with a Significant Economic Burden and Poor Outcome in Patients With Grade III/IV Acute GvHD. Clin Transplant. 2013 Jan-Feb;27(1):E56-63.

Bourne R, Price H, Taylor H, Leasher J, Keeffe J, Glanville J, Sieving PC, Khairallah M, Wong TY, Zheng Y, Mathew A, Katiyar S, Mascarenhas M, Stevens GA, Resnikoff S, Gichuhi S, Naidoo K, Wallace D, Kymes S, Peters C, Pesudovs K, Braithwaite T, Limburg H, Disease Vision Loss Expert Group OB.  New systematic review methodology for visual impairment and blindness for the 2010 global burden of disease study.  Ophthalmic Epidemiol. 2013;20(1):33-9.


NICE Guidance. Craig J, Reay CA, Willits I, Sims A, Hutton A. Mega Soft patient return electrode for use during monopolar electrosurgery (MTG11). NICE External Assessment Centre Report. August 2012.

Renfrew M J, Pokhrel S, Quigley M, McCormick F, Fox-Rushby J, Dodds R, Duffy S, Trueman P, Williams A.  Preventing disease and saving resources: the potential contribution of increasing breastfeeding rates in the UK. Unicef UK, 2012.

Mahon J, Cikalo M, Varley D, Glanville J.  Summaries of the Safety/Adverse Effects of Vaginal Tapes/Slings/Meshes for Stress Urinary Incontinence and Prolapse.  York: York Health Economics Consortium, 2012.

O’Connor AM, Lovei GL, Eales J, Frampton GK, Glanville J, Pullin AS, Sargeant J; Implementation of systematic reviews in EFSA scientific outputs workflow. Supporting Publications 2012:EN-367 [36 pp.].

Lowson KV, Offer C.  Maternal and Infant Health and Care Programme – An Economic Study.  Yorkshire and Humber Health Innovation and Education Cluster.  December 2012

Hard M, Hutton J, Smith B.  Is a Radiographer Led Immediate Reporting Service for Emergency Department Referrals a Cost Effective Initiative?  Radiography 19 (2013) 23-27.

Hex N, Bartlett C, Wright DL, Taylor MJ, Varley D.  Estimating the Current and Future Costs of Type 1 and Type 2 Diabetes in the UK, including Direct Health Costs and Indirect Societal and Productivity Costs.  Diabetic Medicine 2012, 29 (7):855-862.

Spiers G, Gridley K, Cusworth L, Mukherjee S, Heaton J, Atkin K, Birks Y, Lowson KV, Wright DL.  Understanding Care Closer to Home for Ill Children and Young People.  Nursing Children and Young People June 2012, 24 (5)  29-34

Lenoir-Wijnkoop I, Nuijten M. J. C., Gutiérrez Ibarluzea I, Hutton J, Poley M J, Segal L, Bresson J L, van Ganse E, Jones P, Moreno L, Salminen S, Dubois D. Workshop Report: Concepts and Methods in the Economics of Nutrition – Gateways to Better Economic Evaluation of Nutrition Interventions. British Journal of Nutrition

Delea TE, Rotter J, Taylor MJ, Chandiwana D, Bains M, El Ouagari K, Kaura S, Morgan GJ.  Cost-effectiveness of Zoledronic Acid vs Clodronic Acid for Newly-diagnosed Multiple Myeloma from the United Kingdom Healthcare System Perspective. J Med Econ 2012;15(3):454-64

Glanville J, Cikalo M, Crawford F, Dozier M, McIntosh H. Handsearching did not yield additional unique FDG-PET diagnostic test accuracy studies compared with electronic searches: a preliminary investigation. Research Synthesis Methods 2012; doi: 10.1002/jrsm.1046.

Burke MJ, Saxby RC, Taylor MJ.  The Economics of Screening Infants at Risk of Hearing Impairment: An International Analysis.  International Journal of Pediatric Otorhinolaryngology 2012; 76 (2):212-218.

Hutton J.  Health Economics” and the Evolution of Economic Evaluation of Health Technologies.  Health Economics 2012; 21:13-18.


NICE Guidance. Colechin E, Sims A, Reay C, Bousfield D, Allen J. Ambulight photodynamic therapy for the treatment of non-melanoma skin cancer (MTG6). NICE External Assessment Centre Report. July 2011.

Taylor MJ, Leonardi-Bee J, Agboola S, McNeill A, Coleman T.  Cost Effectiveness of Interventions to Reduce Relapse to Smoking Following Smoking Cessation.  Addiction 2011, 106: 1819-1826.

Fletcher MJ, Upton J, Taylor-Fishwick J, Buist SA, Jenkins C, Hutton J, Barnes N, Van Der Molen T, Walsh JW, Jones P and Walker S.  COPD Uncovered: An International Survey on the Impact of Chronic Obstructive Pulmonary Disease (COPD) on a Working Age Population.  BMC Public Health 2011, 11:612.

Lowson KV, Kelly J, Bending M, Whitehead S, Wright D, Lowson P, Duffy S, Trueman P, Saxby RC, West PA.  Cost-effectiveness of Hospital Design: options to improve patient safety and wellbeing. (Patient Safety Research Portfolio Project PS041). York: York Health Economics Consortium; 2011.

Lowson KV, Bending MW, Wright DL and Duffy SB.  Cost-Effectiveness of Hospital Design – A Report and Briefing Paper.  The Patient Safety Research Portfolio (PSRP) on behalf of the Department of Health.  March 2011.

West PA, Lowson KV, Bending M (eds.).  Hospital design – safe and cost effective options (Patient Safety Research Portfolio PS041).  Birmingham: University of Birmingham, Patient Safety Research Portfolio; 2011.

Smith AB, Armes J, Richardson A, Stark DP.  Psychological Distress in Cancer Survivors: The Further Development of an Item Bank.  Psycho-Oncology 22: 308–314 (2013).

Brush J, Boyd K, Chapell F, Crawford F, Dozier M, Fenwick E, Glanville JM, McIntosh H, Renehan A, Weller D, Dunlop M.  The Value of FDG Positron Emission Tomography/Computerised Tomography (PET/CT) in Pre-Operative Staging of Colorectal Cancer: A Systematic Review and Economic Evaluation.  Health Technology Assessment 2011; 15 (35):1-191.

Campbell SM, Kontopantelis E, Hannon K, Burke MJ, Barber A, Lester HE.  Framework and Indicator Testing Protocol for Developing and Piloting Quality Indicators for the UK Quality and Outcomes Framework.  BMC Family Practice, 12:85, 2011.

Mitchell AJ, Smith AB, Al-salihy Z, Rahim TA, Mahmud MQ, Muhyaldin AS.  Redefining Diagnostic Symptoms of Depression Using Rasch Analysis: Testing an Item Bank Suitable For DSM-V and Computer Adaptive Testing.  Australian and New Zealand Journal of Psychiatry. 2011; 45(10):846-52.

Dawson PF, Sharif MO, Smith AB, Brunton PA.  A Clinical Study Comparing the Efficacy And Sensitivity of Home Vs Combined Whitening.  The Open Dentistry Journal. 2011; 36(5):460-6.

Rodgers GD, Sharif MO, Smith AB, Kellett M, Brunton PA.  Making the Grade?  Modification of Dental Radiograph Quality Ratings.  Primary Dental Care.  2011; 18(3):119-24.

Newsham AC, Johnston C, Hall G, Leahy MG, Smith AB, Vikram A, Donnelly AM, Velikova G, Selby PJ, Fisher SE.  Development of an Advanced Database for Clinical Trials Integrated with an Electronic Patient Record System.  Computers in Biology and Medicine.  2011; 41(8):575-86.

Smith AB, Wright P, Selby P, Velikova G.  Measurement Invariance of the 16-item Social Distress Scale.  Quality of Life Research. 2011; 20 (4):507-11.


Whitehead S, Hutton J, Glanville J. SeQuent Please balloon catheter for in-stent coronary restenosis (MTG1). NICE External Assessment Centre Report. December 2010.

NICE Guidance. PH26 Smoking cessation during pregnancy; Tobacco Harm reduction June 2010.

Scuffham PA, Whitty J, Taylor MJ, and Saxby RC.  Health system choice: a pilot discrete choice experiment eliciting the preferences of British and Australian citizens.  Applied Health Economics and Health Policy.  2010 8 (2) 89-97.

Trueman P, Lowson K, Blighe A, Meszaros A, Wright D, Glanville J et al.  Evaluation of the Scale, Causes and Costs of Waste Medicines.  2010. Joint published with the School of Pharmacy, University of London.

Beale S, Trueman P, Sanderson D, Kruger J. The initial evaluation of the Scottish telecare development programme.  Journal of Technology in Human Services.  2010; 28, 60-73.

Bending M, Trueman P, Lowson K, Pilgrim H et al. Estimating the direct costs of bowel cancer services provided by the National Health Service in England.  International Journal of Technology Assessment in Health Care. 2010; 26(4): 1-8.

Glanville J, Paisely S. Identifying economic evaluations for health technology assessment. International Journal of Technology Assessment in Health Care. 2010; 26(4): 436-440.

Lenoir-Wijnkoop I, Dapoigny M, Dubois D, van Ganse E, Gutiérrez-Ibarluzea I, Hutton J, Jones P, Mittendorf T, Poley MJ, Salminen S, Nuijten MJC. Nutrition economics – characterising the economic and health impact of nutrition. British Journal of Nutrition. 2010; 1-9.

Remak E, Manson S, Hutton J, et al. Cost-effectiveness of the endeavour stent in de novo native coronary artery lesions updated with contemporary data. Eurointervention. 2010; 5(7): 826-832.

Trueman P, Whitehead S. The economics of pressure relieving surfaces: an illustrative case study of the impact of high-specification surfaces on hospital finances. International Wound Journal. 2010; 7(1): 48-54.


Taylor M , Scuffham P, Chaplin S, Papo N. An economic evaluation of Valsartan for post-MI patients in the UK who are not suitable for treatment with ACE inhibitors.  Value in Health. 2009; 12(4): 459-465.

Glanville J. Searching the literature: resources available. The Foundation Years 2009;5(1):28-30.

Glanville J, Kaunelis D, Mensinkai S. How well do search filters perform in identifying economic evaluations in MEDLINE and EMBASE. International Journal of Technology Assessment in Health Care 2009;25(4).

Stamuli E, Kruger J, Hutton J.  Cost-effectiveness of Ultrasound Elastography in the Assessment of Liver Fibrosis.  Centre for Evidence-Based Purchasing Economic Report CEP08053.  February 2009.

Beale SJ, Sanderson DJ, Kruger J.  Evaluation of the Telecare Development Programme.  Joint Improvement Team, Scottish Executive. 2009.

Trueman P, Hurry M, Bending M, Hutton J. The feasibility of harmonizing health technology assessments across jurisdictions: a case study of drug eluting stents. International Journal of Technology Assessment in Health Care. 2009; 25(4): 455-462.

Taylor MJ, Scuffham PA.  Pharmacoeconomic benefits of dasatinib in chronic myelogenous leukaemia.  Expert Review of Pharmacoeconomics and Outcomes Research 2009: 9(2); 117-121

Taylor MJ. What is sensitivity analysis?  What Is. Series.  Hayward Medical Communications 2009.

Perry AE, Neale Z, Godfrey C, McDougall C, Glanville J, Coulton S. The effectiveness of interventions for drug-using offenders in the courts, secure establishments and the community. Journal of Substance Use and Misuse. 2009, 44(3); 974-400

Perry A, Coulton S, Glanville J, Godfrey C, Lunn J, McDougall C, Neale Z. Interventions for drug-using offenders in the courts, secure establishments and the community. Cochrane Database of Systematic Reviews. 2009, Issue 3; 1-63.

Taylor MJ. UK economic evaluation and vaccination policy. Vaccines in Practice. 2009, 2(3)


NICE Guidance. PH10 Smoking cessation services Feburary 2008.

Whiting P, Westwood M, Burke M, Sterne J, Glanville J. Systematic reviews of test accuracy should search a range of databases to identify primary studies. Journal of Clinical Epidemiology 2008; 61:4, 357-364.

Hutton J, Beale SJ, Kruger J, Chaplin S (2008).  Cardiovascular Services in England: Opportunities and Challenges over the Next Ten Years.  Cardio and Vascular Coalition.

Glanville J, Sue Bayliss, Andrew Booth, Yenal Dundar, Hasina Fernandes, Nigel David Fleeman, Louise Foster, Cynthia Fraser, Anne Fry-Smith, Su Golder, Carol Lefebvre, Caroline Miller, Suzy Paisley, Liz Payne, Alison Price and Karen Welch, on behalf of the ISSG. So many filters, so little time: the development of a search filter appraisal checklist. J Med Libr Assoc. 2008 October; 96(4): 356-361.

Lefebvre C, Manheimer E, Glanville J, on behalf of the Cochrane Information Retrieval Methods Group.  Chapter 6: Searching for studies. IN: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. (Cochrane Book Series). Chichester, UK: The Cochrane Collaboration and John Wiley & Sons, Ltd., 2008: 95-150

Hutton J, Trueman P, Facey K.  Harmonization of evidence requirements for health technology assessment in reimbursement decision making.  International Journal of Technology Assessment in Health Care 2008, 24(4): 511-517.

Muszbek N, Thompson MM, Soong CV, Hutton J, Brasseur P, van Sambeek MRHM.  Systematic Review of Utilities in Abdominal Aortic Aneurysm.  European Journal of Vascular and Endovascular Surgery 2008, 36(3): 283-289.

Trueman P, Taylor MJ, Twena N, Chubb B.  The Cost of Needlestick Injuries associated with Insulin Administration.  British Journal of Community Nursing 13 (9) 413-417, September 2008.

Trueman P. Cost-effectiveness Considerations for Home Health V.A.C®.Therapy in the United States of America and its Potential International Application.  International Wound Journal 5 (s2), 23-26, 2008.

Trueman P, Flack S, Loonstra A, Hauser T.  The Feasibility of Using V.A.C.® Therapy in Home Care Patients with Surgical and Traumatic Wounds in the Netherlands.  International Wound Journal 5 (2), 225–231, 2008.

Lowson K, Lankshear A, Harden J, Lowson P, Wright D, Saxby R, Jones A, Mardell A, and Greenough K. (2008) ‘A Multi-Method Study of the Uptake of Advice, Directives and Guidelines to the NHS Concerning Patient Safety by the Safety Alert Broadcast System’. Report for the Patient Safety Research Portfolio.

The Counterweight Programme (Inc. P Trueman). Influence of overweight and obesity on prescribing costs and cost savings of an effective weight management programme in routine primary care: the Counterweight programme. J Health Serv Res Policy 2008;13:158-166, 2008.

Bending MW, Beale S, Hutton J. An Economic Analysis of Workplace Interventions that Promote Physical Activity. PHIAC Report. National Institute for Health and Clinical Excellence.  April 2008.

Taylor MJ, Elgazzar HA, Chaplin S, Goldsmith D, Molony DA.  An Economic Evaluation of Sevelamer in Patients New to Dialysis.  Current Medical Research and Opinion, 2008; 24(2): 601-608.

Flack S, J Apelqvist, M Keith, P Trueman, D Williams.  An economic evaluation of VAC therapy compared with wound dressings in the treatment of diabetic foot ulcers.  Journal of Wound Care, Vol. 17, Iss. 2, 31 Jan 2008, pp 71 – 78

Croucher K, Sanderson DJ, Chaplin S, Wright DL, Lowson KV.  A study of the supply and condition of sheltered housing; changes and barriers to change; costs and demand issues; residents’ experiences; and the future housing aspirations of older people.  The Scottish Government.  14 January 2008.

Dale PL, Hutton J,  Elgazzar H,  Utility of health states in chronic kidney disease: a structured review of the literature, Current Medical Research and Opinion, 2008; 24(1): 193-206.


Hutton J, Trueman P, Henshall C.  Coverage with Evidence Development: An Examination of Conceptual and Policy Issues.  International Journal of Technology Assessment in Health Care, 2007, 23(4); 425-435.

Knopf K.B, Hutton J, Value and use of economic evaluation in oncology, J Clinical Oncology, December 2007; 25(35): 5666-5667.

Lowson K, Young J, Green J, Forster A, Small N, Bogle S, George J, Heseltine D, Jayasuriya T, and Rowe J.  Post acute Care for Older People in Community Hospitals: A Multicenter Randomized, Controlled Trial, JAGS, November 2007.

Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Watkins J, Trueman P.  Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis.  Value Health. 2007 Sep-Oct;10 (5):336-47

Beale S, Bending MW, Hutton J, A Rapid Review of Economic Literature: Workplace Health Promotion – How to Encourage Employees to be Physically Active. PHIAC Report. National Institute for Health and Clinical Excellence. August 2007.

Trueman P, Flack SM.  Local modelling: The adoption of simple modelling approaches geared towards informing local decision-making has much to offer healthcare professionals in determining the real costs of wound care treatments.  Healthcare Equipment and Supplies (HES).  July/August 2007: 16-17.

Ulrich R, Simmonds, M, Young P, Buisseret A, Howells, A, Warren W, Millman, J, Hastie, D, Hametz, I, Place, B, Bending, MW.  Symposium on Single Bed Ward Accommodation, The Estate We’re In.  June 2007.

Beale S, Bending MW, Trueman P.  An Economic Analysis of Environmental Interventions that Promote Physical Activity PDG Report. National Institute for Health and Clinical Evidence.  April 2007

Beale S, Bending MW, Yi Y, Trueman P, A Rapid Review of Economic Literature Related to Environmental Interventions that Increase Physical Activity Levels in the General Population. PDG Report. National Institute for Health and Clinical Evidence. March 2007

Small N, Green J, Spink J, Forster A, Lowson K, Young J  The patient experience of community hospital – the process of care as a determinant of satisfaction.  The Journal of Evaluation in Clinical Practice. 13: 95–101.  February 2007.

Taylor MJ, Scuffham PA, McCollam P, Newby D.  Acute Coronary Syndromes in Europe: One-year costs and outcomes.  Current Medical Research and Opinion, 2007; 23 (3), 495-503.

Home P, Bagust A, Taylor MJ, Ambery P, Mendes da Costa S. A lifetime modelled economic evaluation comparing pioglitazone and rosiglitazone for the treatment of type 2 diabetes mellitus in the UK. Pharmacoeconomics. 2007, 25 (9) 801-802

Ritchie G, Glanville J, Lefebvre C. Do published search filters to identify diagnostic test accuracy studies perform adequately? Health Information and Libraries Journal. 2007, 24 (3) 188-192


NICE Guidance. CG43 Obesity: The prevention, identification, assessment and management of overweight and obesity in adults and children December 2006.

Téot L, Cherry G, Denis C, Dervaux B, Duncan G, Gottrup F, Harding K, Kerihuel JC, Lautenberg A, Mani R, Meaume S, Messina R, Morris S, Orsted H, Pavlovic M, Peter R, Ricci E, Sibbald G, Sussmann G, Trueman P; World Union of Wound Healing Societies.Reimbursement of dressings: a WUWHS statement. Int Wound J. 2006 Dec;3(4):296-301.

Flack S, Taylor M, Trueman P.  A Rapid review of the cost effectiveness of workplace interventions for smoking cessation in England. Final Report. National Institute for Health & Clinical Excellence, December 2006.

O Reilly J, Trueman, P, Redmond SM et al.  Cost Benefit Analysis of Health Impact Assessment. Department of Health Report, November 2006.

Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Tam T, Trueman P, Watkins J, Wilson A. Principles of Good Practice for Budget Impact Analysis.  Report of the ISPOR Task Force on Good Research Practices – Budget Impact Analysis.  September 2006

Trueman P, Posnett J.  What Price Wound Care? (Editorial).  Publication pending. International Journal of Leg and Extremity Wounds.

O’Reilly, J., Lowson, K., Young, J., Forster, A., Green, J., Small, N.  A cost effectiveness analysis within a randomised controlled trial of post-acute care of older people in a community hospital.  BMJ  2006;333:228 (29 July).0: p. bmj.38887.558576.7Cv1

Beale SJ, Bagust A, Shearer A, Martin A, Hulme L.  Cost-effectiveness of Rosiglitazone Combination Therapy for the Treatment of Type 2 Diabetes Mellitus in the UK.  PharmacoEconomics 2006; 24: 20 -34.

Meszaros A & Taylor MJ.  Determining the Factors that Contribute Towards NICE Decision Making: A binary choice model.  June 2006.

O’Reilly JM, Trueman P, Ganderton MI, Wright DL.  Results of a Census of Temporary Nursing Staff in Acute Hospital and Foundation Trusts.  Report for the National Audit Office.  May 2006.

Bagust A, Evans M, Beale SJ, Home PD, Perry AS, Stewart M.  A Model of Long-term Metabolic Progression of Type 2 Diabetes Mellitus for Evaluating Treatment Strategies.  PharmacoEconomics 2006; 24: 5-19.

Brown P, Brunnhuber K, Chalkidou K, Chalmers I, Clarke M, Fenton M, Forbes C, Glanville J, Hicks NJ, Moody J, Twaddle S, Timimi H, Young P. How to formulate research recommendations. British Medical Journal.  2006, 333; 804-6

Davies A, Hutton J, O’Donnell J, Kingslake S. Cost-effectiveness of rosuvastatin, atorvastatin, simvastatin, pravastatin and fluvastatin for the primary prevention of CHD in the UK. British Journal of Cardiology. 2006, 13(3); 196-202

Gilbody S, Cahill J, Barkham M, Richards D, Bee P, Glanville J. Can we improve the morale of staff working in psychiatric units? A systematic review. Journal of Mental Health. 2006. 15 (1) 7-17

Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association. 2006, 94(2) 130-136

Golder S, McIntosh HM, Duffy S, Glanville J. Developing efficient search strategies to identify reports of adverse effects in MEDLINE and EMBASE. Health Information and Libraries Journal. 2006, 23 (1); 3-12

Hutton J, McGrath C, Frybourg JM, Tremblay M, et al. Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems). International Journal of Technology Assessment in Health Care. 2006, 22 (1); 1-9

O’Reilly JM, Lowson KV, Young J, Forster A, Green J, Small N. A cost-effectiveness study of community hospital care for older people. British Medical Journal. 2006,333 (7561) July; 228

Richards D, Bee P, Barkham M, Gilbody SM, Cahill J, Glanville J. The prevalence of nursing staff stress on adult acute psychiatric inpatient wards: a systematic review. Social Psychiatry & Psychiatric Epidemiology. 2006, 41(1) 34-43

Small N, Green J, Spink J, Forster A, Lowson KV and Young J. The patient experience of community hospital: the process of care as a determinate of satisfaction. Journal of Evaluation in Clinical Practice. 2006, 13 (1) 95-101

Whiting P, Westwood M, Bojke L, Palmer S, Richardson G, Cooper J, Watt I, Glanville J, Sculpher M, Kleijnen J. Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model. Health Technology Assessment. 2006, 10(36) 1-382


Spencer A, Chilton SM, Covey J, Taylor MJ.  Testing the Internal Consistency of the Lottery Equivalent Method Using Health Outcomes: A Comment to Oliver.  Health Econ. 14: 161–167 (2005).

Bagust A, Beale SJ.  Modelling EuroQol Health-related Utility Values for Diabetic Complications from CODE-2 Data.  Health Economics 2005; 14: 217-230.

Green J, Young J, Forster A, Mallinder K, Bogle S, Lowson KV, Small N.  Effects of Locality Based Community Hospital Care on Independence in Older People Needing Rehabilitation: Randomised Controlled Trial.  BMJ; August 2005; 331: 317 – 322.

Lankshear AJ, Sheldon TA, Lowson KV, Watt IS, Wright J.  Evaluation of the Implementation of the Alert Issued by the UK National Patient Safety Agency on the Storage and Handling of Potassium Chloride Concentrate Solution.  Qual Saf Health Care 2005, June; 14(3):196-201.

Mahon A, Harris C, Tyrer J, Carr S, Lowson KV, Carr L, Chaplin S, Wright DL.  The Implementation and Impact of “Hospital at Night” Pilot Projects: An Evaluation Report.  Department of Health.  May 2005 pp1-50.

Skevington SM, Day R, Chisholm A, Trueman P. How much do doctors use Quality of Life Information in Primary Care? Testing the Trans-Theoretical Model of Behaviour Change.  Quality of Life Research 14(4): 911-922; 2005.

Watson R, Hogston R, Norman I, Stimpson A, Sanderson DJ, O’Reilly JM, Baulcomb S.  Quality Assurance in UK Nursing Education: Public Protection in the Era of Streamlined Assessment.  Nurse Education Today. Vol 25 (1) 49-55.  January 2005.

Aguiar-Ibanez R, Nixon J, Glanville J, Craig D, Rice S, Christie J, Drummond MF. Economic evaluation databases as an aid to healthcare decision makers and researchers. Expert Review of Pharmacoeconomics & Outcomes Research. 2005, 5 (6) 721-732

de Pouvourville G, Ulmann P, Nixon J, Boulenger S, Glanville JM, Drummond MF. The diffusion of health economics knowledge in Europe:  the EURONHEED (European Network of Health Economics Evaluation Database) project. Pharmacoeconomics. 2005, 23(2); 113-120

Golder S, Glanville J, Ginnelly L. Populating decision-analytic models: the feasibility and efficiency of database searching for individual parameters. International  Journal of Technology Assessment in Health Care


Sheldon TA, Cullum N, Dawson D, Lankshear A, Lowson KV, Watt I, West PA, Wright DL, Wright J.  What’s the Evidence that NICE Guidance has been Implemented?  Results from a National Evaluation using Time Series Analysis, Audit of Patients; Notes, and Interviews.  BMJ 2004; 329; 999, 30 October 2004.

Taylor MJ.  The Measurement of Health Improvements: An alternative to QALYs Gained.  November 2004.

Street A, Lowson KV.  Do Tariffs Stack Up in HSJ, 8 January 2004.

Nixon J, Duffy S, Armstrong N, Craig D, Glanville J M, Christie J, Drummond M F,  Kleijnen J. The usefulness of the NHS Economic Evaluation Database to researchers undertaking technology assessment reviews. International Journal of Technology Assessment in Health Care. 2004, 20 (3) 249-257

Nixon J, Ulmann P, Glanville J, Boulenger S, Drummond M, de Pouvourville G. The European Network of Health Economic Evaluation Databases (EURO NHEED) Project. European Journal of Health Economics. 2004, 5, 183-187

Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technology Assessment. 2004 8(36), 1-172


Bagust A, Beale SJ.  Deteriorating Beta-Cell Function in Type 2 Adults: A Long Term Model.  Quarterly Journal of Medicine 2003; 96: 281-288.

Sanderson DJ, Limber C, Eldred C, Harrison K.  To the ENT Degree.  Health Service Journal, 113 (5844); 26-27 (27 February 2003).

Scuffham PA, Carr LM.  An Economic Evaluation of Continuous Subcutaneous Insulin Infusion Pumps Compared with Multiple Daily Injections.  Diabetic Medicine 2003; vol: 20; 586-593

Gordois A, Scuffham PA, Warren E, Ward S.  “The Cost-effectiveness of Glivec for the Treatment of Accelerated and Blast Phases of Chronic Myeloid Leukaemia”.  British Journal of Cancer 2003; Vol 89 (4): 634-40.

Gordois A, Scuffham PA, Shearer A, Oglesby A.  “The Costs and Consequences of Peripheral Neuropathy in the UK”.  The Diabetic Foot 2003; Vol 6:1; 30-37.

Scuffham PA.  “Estimating Influenza-Related Hospital Admissions in Children and Adults:  A Time-Series Analysis”.  Disease Management and Health Outcomes 2003; Vol 11:4; 259-269.

Scuffham PA, Chaplin S, Legood R.  “The Incidence and Costs of Accidental Falls in Older People in the UK”.  Journal of Epidemiology and Community Health 2003; Vol 57; 740-744.

Bagnall A-M, Jones L, Ginnelly L, Lewis R, Glanville J, Gilbody S, Davies L, Torgerson D. A systematic review of atypical antipsychotic drugs in schizophrenia. Health Technology Assessment. 2003, 7(13) 1-502

Bagust A, Schoeffski O, Shearer A, Goertz A, Reitberger U, Behrens M. The DiDACT economic model of type 2 diabetes for Germany. Diabetes und Stoffwechsel. 2002. 12(Suppl 1); 159

Glanville J, Wilson P, Richardson R. Accessing the online evidence: a guide to key sources of research information on clinical and cost effectiveness. Quality & Safety in Health Care. 2003, 12(3) 229-231

Nixon J, Duffy SB, Craig D, Armstrong N, Christie J, Glanville JM, Drummond MF, Kleijnen J. Improving outcomes through access to critiqued economic evaluations: the NHS Economic Evaluation Database within the HTA review process. Value in Health. 2003, 6(3); 211

Wilson P, Glanville G, Watt I. Access to the online evidence base in general practice: a survey of the Northern and Yorkshire Region. Health Information and Libraries Journal. 2003, 20(3); 172-178

Bagust A, Shearer A, Schoeffski O, Reitberger U, Goertz A, Behrens M. Cost-effectiveness in Germany of rosiglitazone-metformin combination in type 2 diabetes. Diabetologia. 2003, 46 (supple 2); A444

Gordois A, Scuffham PA, Shearer A, Oglesby A. The health care costs of diabetic nephropathy in the United Kingdom and the United States. Diabetes. 2003, 52 (Suppl 1); A185-186


Bent N, Tennant A, Swift T, Posnett JW, Scuffham PA, Chamberlain MA.  “Ad Hoc or Focussed Services for Young People with Physical Disabilities?”  The Lancet 2002; Vol 360:9342; 1280-1286.

Scuffham PA, Legood R, Wilson E, Martin-Kennedy T.  “The Cost of Accidental Falls Associated with Visual Impairment” Visual Impairment Research 2002; Vol 4:1; 1-14.

Scuffham PA, Taylor MJ.  Economics and Decisions to End Life: van Acht and Stooker revisited.  Applied Health Economics and Health Policy 2002: 1(3); 123-128.

Armstrong N, Drummond M, Nixon J, Craig D, Glanville J. How do we judge the quality of economic evaluations? Journal of Clinical Excellence. 2002 4(3); 345-347

Glanville J. Management briefing: performance indicators [web pages]. National Electronic Library for Health. 2002

Hoffmann C, Stoykova BA, Nixon J, Glanville JM, Misso K, Drummond MF. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. Value in Health. 2002, 5 (2); 71-78

Nixon J, Phipps K, Drummond MF, Mugford M, Glanville JM. Using economic evidence to support decision-making:  a case study of assertive community treatment within the UK National Service Framework for Mental Health. Applied Health Economics and Health Policy. 2002, 1(4) 179-190

Robinson M, Ginnelly L, Sculpher M, Jones L, Riemsma R, Palmer S, Philips Z, Glanville J. A systematic review update of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists. Health Technology Assessment. 2002, 6 (25) 1-160

Smith D, Dempster C, Glanville J, Freemantle N, Anderson IM. Efficacy and tolerability of venlafaxine compared with selective serotonic reuptake inhibitors and other antidepressants: a meta-analysis. British Journal of Psychiatry. 2002, 180; 394-404

Taylor MJ. Scuffham PA. New Zealand bicycle helmet law: do the costs outweigh the benefits? Injury Prevention. 2002, 8; 317-320


Lewis R, Whiting P, ter Riet G, O’Meara S, Glanville J. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention. Health Technology Assessment. 2001, 5(14); 1-131

Riemsma RP, Forbes CA, Glanville JM, Eastwood AJ, Kleijnen J. General health status measures for people with cognitive impairment: learning disability and acquired brain injury. Health Technology Assessment. 2001, 5 (6); 1-100

White VJ, Glanville JM, Lefebvre C, Sheldon TA. A statistical approach to designing search filters to find systematic reviews: objectivity enhances accuracy. Journal of Information Science. 2001 27 (6) 357-70

Wilson P, Droogan J, Glanville J, Watt I, Hardman G. Access to the evidence base from general practice: a survey of general practice staff in Northern and Yorkshire Region. Quality in Health Care. 2001, 10 (2) 83-89


Droogan J, Glanville J, Watt I, Wilson P. Access to the evidence base from general practice in Northern and Yorkshire Region: report to NHSE Northern & Yorkshire Region. York: NHS Centre for Reviews and Dissemination. 2000

Glanville J, Smith I.  Evaluating the options for developing databases to support research-based medicine at the NHS Centre for Reviews and Dissemination.  International Journal of Medical Informatics. 2000, 47; 83-86

Nixon J, Stoykova BA, Christie J, Glanville JM, Kleijnen J, Drummond MF. The NHS economic evaluation database for healthcare decision makers. British Medical Journal. 2000, 321; 32

Nixon J, Stoykova BA, Glanville JM, Christie J, Drummond MF, Kleijnen J. The UK NHS economic evaluation database: economic issues in evaluations of health technology. International Journal of Technology Assessment in Health Care. 2000, 16 (3) 731-742